Radar on Drug Benefits

For PBMs, Amazon Pharmacy May Be Both Friend and Foe

Amazon.com, Inc. made a splash in the health care world on Nov. 17 when the online retail powerhouse unveiled new pharmacy offerings that aim to disrupt the prescription drug market with increased convenience and sa...
0 Comments
© 2024 MMIT

News Briefs

✦ Prime Therapeutics LLC, the PBM co-owned by 18 Blue Cross and Blue Shield plans, hired a new data analytics executive team. The new hires include Urvi Randhar as senior vice president and chief information and t...
0 Comments
© 2024 MMIT

Insurers Prepare to Pay For, Help Distribute COVID Vaccine With Chart: Coronavirus Vaccine Effort Gets Closer to Finish Line

As details continue to emerge about the availability of COVID-19 vaccines and how they will be administered, the role that payers will play in the process is becoming clearer. It’s imperative for health plans t...
0 Comments
© 2024 MMIT

Biden May Have to Settle for Smaller Drug-Pricing Moves

As is the case for other flavors of health care reform, President-elect Joe Biden’s chance of passing substantial, transformative drug-pricing legislation is now highly dependent upon whether Democrats can eke out...
0 Comments
© 2024 MMIT

PBM Revenues Offer Boost to Major Insurers in Third Quarter

Large insurer-affiliated PBMs saw strong results for the third quarter of 2020, in several cases driving revenues for parent companies that are grappling with various disruptive effects of the coronavirus pandemic. ...
0 Comments
© 2024 MMIT

States Eye Expanded Drug Price Review Boards as Costs Rise

In response to rising drug prices, some states have launched prescription drug review boards designed to make medicines more affordable. So far, the boards control prices mainly for states’ Medicaid and state empl...
0 Comments
© 2024 MMIT

Humana Expects Medicare PDP Membership ‘Headwind’ in 2021

Judging by executives’ comments during its third-quarter 2020 earnings conference call, Humana Inc. is finding it difficult to stand out in the fiercely competitive market for stand-alone Medicare Prescription Dru...
0 Comments
© 2024 MMIT

Part D, Private Plan Spending Rises on Retail Specialty Drugs

Specialty drugs accounted for 37.7% of retail and mail-order prescription spending, net of rebates, in 2016 and 2017, according to a recent study published in Health Affairs. Average annual net spending on retail sp...
0 Comments
© 2024 MMIT

News Briefs

✦ Pfizer Inc. and BioNTech SE’s coronavirus vaccine candidate has demonstrated 90% efficacy against COVID-19 in patients that have not had the disease, according to company researchers. The announcement was met ...
0 Comments
© 2024 MMIT

Prime-Express Scripts Merger Looks Unlikely Despite New Deal

Prime Therapeutics, the PBM jointly owned by 18 Blue Cross Blue Shield plans, recently entered an agreement with Cigna Corp.-owned PBM Express Scripts to offer Blues plans the option of using Express Scripts’ mail...
0 Comments
© 2024 MMIT